What does metformin do
Pro Research Analysisby 
Searched over 200M research papers
Understanding the Multifaceted Actions of Metformin
Introduction to Metformin and Its Primary Uses
Metformin is a widely-used biguanide drug primarily prescribed for the management of type 2 diabetes mellitus (T2DM). It is favored due to its efficacy in lowering blood glucose levels, safety profile, and cost-effectiveness 37. Despite its long-standing use, the precise mechanisms by which metformin exerts its effects remain complex and not fully understood 13.
Mechanisms of Action: Hepatic Glucose Production and AMPK Activation
Inhibition of Hepatic Gluconeogenesis
One of the primary actions of metformin is the inhibition of hepatic glucose production. This is achieved through a mild and transient inhibition of the mitochondrial respiratory chain complex I, which leads to a decrease in hepatic energy status and subsequent activation of AMP-activated protein kinase (AMPK) 78. AMPK activation plays a crucial role in reducing acetyl-CoA carboxylase (ACC) activity, inducing fatty acid oxidation, and suppressing the expression of lipogenic enzymes 5.
AMPK-Dependent and Independent Pathways
Metformin's effects are mediated through both AMPK-dependent and AMPK-independent mechanisms. While AMPK activation is a well-accepted pathway, recent studies have shown that metformin can also inhibit mitochondrial glycerophosphate dehydrogenase and affect the lysosome, indicating a more complex mode of action 14. Additionally, metformin's ability to alter cellular redox balance supports a redox-dependent mechanism of action 3.
Metformin and the Gut Microbiome
Alteration of Gut Microbiota
Emerging evidence suggests that the gut microbiota plays a significant role in mediating some of metformin's antidiabetic effects. Studies have shown that metformin treatment leads to significant changes in the gut microbiome composition, which in turn improves glucose tolerance 2. This interaction between metformin and the gut microbiota highlights an additional layer of complexity in its mechanism of action.
Beyond Glucose Control: Pleiotropic Effects
Cardiovascular Benefits
Metformin has been associated with various cardiovascular benefits, including reduced risk of myocardial infarction and improved prognosis in patients with congestive heart failure (CHF) 9. These cardioprotective effects are thought to be mediated through increased AMPK phosphorylation and enhanced nitric oxide production in cardiomyocytes, independent of its glucose-lowering properties 9.
Impact on Lipid Metabolism and Inflammation
Metformin also exerts beneficial effects on lipid metabolism by reducing fatty liver and improving systemic insulin sensitivity. It decreases the secretion of lipids from intestinal epithelial cells and enhances fatty acid oxidation in adipose tissue and muscles 4. Additionally, metformin helps maintain intestinal barrier integrity and alleviates low-grade inflammation, further contributing to its therapeutic effects 4.
Potential Anti-Cancer Properties
Recent studies have explored metformin's potential anti-tumorigenic effects. Metformin may inhibit cancer cell growth through AMPK activation, which in turn inhibits the mammalian target of rapamycin (mTOR) pathway. Other non-AMPK dependent pathways, such as reduction of insulin and inflammatory markers, may also play a role in its anti-cancer effects 10. However, clinical evidence supporting the use of metformin in cancer treatment remains inconclusive 10.
Conclusion
Metformin is a multifaceted drug with a primary role in managing type 2 diabetes through the inhibition of hepatic glucose production and activation of AMPK. Its effects extend beyond glucose control, influencing lipid metabolism, gut microbiota, and potentially offering cardiovascular and anti-cancer benefits. Despite decades of research, the full spectrum of metformin's mechanisms remains an active area of investigation, underscoring the need for continued research to fully elucidate its therapeutic potential.
Sources and full results
Most relevant research papers on this topic
The mechanisms of action of metformin
Metformin improves glucose metabolism and diabetes-related complications through multiple mechanisms, including reducing hepatic glucose production and a key role for the gut.
Rigorous Journal
Highly CitedMetformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Metformin alters the gut microbiome in individuals with treatment-naive type 2 diabetes, contributing to its therapeutic effects and improving glucose tolerance.
RCT
Very Rigorous JournalHighly CitedCellular and Molecular Mechanisms of Metformin Action
Metformin's glucose-lowering effect in type 2 diabetes patients is mainly mediated through inhibition of hepatic gluconeogenesis, with a redox-dependent mechanism of action being proposed.
Literature ReviewHighly CitedMetabolic Action of Metformin
Metformin effectively suppresses hepatic glucose production, improves insulin sensitivity, and alters gut microbiota composition, maintaining intestinal barrier integrity, and reducing inflammation in type 2 diabetes patients.
Role of AMP-activated protein kinase in mechanism of metformin action.
Metformin's beneficial effects on lipids and glucose metabolism are due to activation of AMP-activated protein kinase, which reduces lipogenic enzyme expression and inhibits glucose production in hepatocytes.
Non-RCT
Animal StudyHighly CitedMetformin: An Old Drug with New Applications
Metformin may treat nonalcoholic fatty liver disease, cancer, obesity, and metabolic syndrome, but more clinical evidence is needed to confirm its benefits and prevent liver tumorigenesis.
Highly CitedMetformin: clinical use in type 2 diabetes
Metformin is a popular oral glucose-lowering medication for type 2 diabetes, with benefits including improved lipids, reduced cardiovascular events, and a lenient regulatory approach for patients with mild renal dysfunction.
Rigorous JournalHighly CitedCellular and molecular mechanisms of metformin: an overview.
Metformin reduces hepatic glucose production and activates AMPK, offering potential new therapeutic areas and personalized medicine in Type 2 diabetes treatment.
Highly CitedCardioprotection by Metformin: Beneficial Effects Beyond Glucose Reduction
Metformin has cardioprotective properties beyond glucose reduction, potentially improving heart health and reducing the risk of reinfarction and all-cause mortality in patients with coronary artery disease and congestive heart failure.
Meta-AnalysisVery Rigorous JournalMetformin in cancer.
Metformin may have potential anti-tumorgenic effects, but its effectiveness in treating cancer remains inconclusive.
Highly Cited